Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and carboplatin in intermediate-risk endometrial cancer
NCT00584909Phase 2Terminated
- Sponsor
- University of Alabama at Birmingham
- Start
- Mar 2006
- Primary completion
- Sep 2010
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, carboplatin in endometrial adenocarcinoma, sponsored by University of Alabama at Birmingham. Started Mar 2006; status: terminated.
02
Drugs
Paclitaxel Micelles for Injectioncarboplatin
03
Conditions
endometrial adenocarcinoma
Beyond the preview
Go deeper on NCT00584909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00584909.